Treatment for a Subtype of Exudative Macular Degeneration-Another Mountain Climbed

Gregg T Kokame^{1

2}, Judy E Kim³

Affiliations

¹ Division of Ophthalmology, Department of Surgery, University of Hawaii John A. Burns School of Medicine, Honolulu.
² Hawaii Macula and Retina Institute, Aiea.
³ The Eye Institute, Medical College of Wisconsin, Milwaukee.

Comment

Gregg T Kokame et al. JAMA Ophthalmol. 2020.

. 2020 Sep 1;138(9):942-944.

doi: 10.1001/jamaophthalmol.2020.2421.

Gregg T Kokame^{1

2}, Judy E Kim³

¹ Division of Ophthalmology, Department of Surgery, University of Hawaii John A. Burns School of Medicine, Honolulu.
² Hawaii Macula and Retina Institute, Aiea.
³ The Eye Institute, Medical College of Wisconsin, Milwaukee.

No abstract available

Comment on

Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial.
Lim TH, Lai TYY, Takahashi K, Wong TY, Chen LJ, Ruamviboonsuk P, Tan CS, Lee WK, Cheung CMG, Ngah NF, Patalauskaite R, Margaron P, Koh A; EVEREST II Study Group. Lim TH, et al. JAMA Ophthalmol. 2020 Sep 1;138(9):935-942. doi: 10.1001/jamaophthalmol.2020.2443. JAMA Ophthalmol. 2020. PMID: 32672800 Free PMC article. Clinical Trial.